Cargando…

Age-specific risks, severity, time course, and outcome of bleeding on long-term antiplatelet treatment after vascular events: a population-based cohort study

BACKGROUND: Lifelong antiplatelet treatment is recommended after ischaemic vascular events, on the basis of trials done mainly in patients younger than 75 years. Upper gastrointestinal bleeding is a serious complication, but had low case fatality in trials of aspirin and is not generally thought to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Linxin, Geraghty, Olivia C, Mehta, Ziyah, Rothwell, Peter M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537194/ https://www.ncbi.nlm.nih.gov/pubmed/28622955 http://dx.doi.org/10.1016/S0140-6736(17)30770-5

Ejemplares similares

Incidence, outcome, risk factors, and long-term prognosis of cryptogenic transient ischaemic attack and ischaemic stroke: a population-based study
por: Li, Linxin, et al.
Publicado: (2015)

Time course of blood pressure control prior to lacunar TIA and stroke: Population-based study
por: Li, Linxin, et al.
Publicado: (2018)

Long-Term Premorbid Blood Pressure and Cerebral Small Vessel Disease Burden on Imaging in Transient Ischemic Attack and Ischemic Stroke: Population-Based Study
por: Lau, Kui Kai, et al.
Publicado: (2018)

Recent time trends in incidence, outcome and premorbid treatment of atrial fibrillation-related stroke and other embolic vascular events: a population-based study
por: Yiin, Gabriel S C, et al.
Publicado: (2017)

Medical Attention Seeking After Transient Ischemic Attack and Minor Stroke Before and After the UK Face, Arm, Speech, Time (FAST) Public Education Campaign: Results From the Oxford Vascular Study
por: Wolters, Frank J., et al.
Publicado: (2018)

Refining prediction of major bleeding on antiplatelet treatment after transient ischaemic attack or ischaemic stroke
por: Hilkens, Nina A, et al.
Publicado: (2020)

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
por: Hilkens, Nina A., et al.
Publicado: (2018)

Effect of coexisting vascular disease on long-term risk of recurrent events after TIA or stroke
por: Boulanger, Marion, et al.
Publicado: (2019)

Effects of aspirin on risk and severity of early recurrent stroke after transient ischaemic attack and ischaemic stroke: time-course analysis of randomised trials
por: Rothwell, Peter M, et al.
Publicado: (2016)

Time Course of Evolution of Disability and Cause‐Specific Mortality After Ischemic Stroke: Implications for Trial Design
por: Ganesh, Aravind, et al.
Publicado: (2017)

Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials
por: Rothwell, Peter M, et al.
Publicado: (2018)

Management of Bleeding Events Associated with Antiplatelet Therapy: Evidence, Uncertainties and Pitfalls
por: Godier, Anne, et al.
Publicado: (2020)

Dual Antiplatelet Therapy and the Severity Risk of Lower Intestinal Bleeding
por: Carlin, Neal, et al.
Publicado: (2017)

Long-Term Prognosis of Patients With Transient Ischemic Attack or Stroke and Symptomatic Vascular Disease in Multiple Arterial Beds
por: Heldner, Mirjam R., et al.
Publicado: (2018)

Severe non-traumatic bleeding events detected by computed tomography: do anticoagulants and antiplatelet agents have a role?
por: Risch, Olivier, et al.
Publicado: (2014)

Long-term dual antiplatelet treatment and bleeding complications in diabetic patients treated with drug eluting stent implantation
por: Voudris, Vassilis, et al.
Publicado: (2014)

Associations of Multimorbidity With Stroke Severity, Subtype, Premorbid Disability, and Early Mortality: Oxford Vascular Study
por: Downer, Matthew B., et al.
Publicado: (2023)

Impact of Different Operational Definitions on Mild Cognitive Impairment Rate and MMSE and MoCA Performance in Transient Ischaemic Attack and Stroke
por: Pendlebury, Sarah T., et al.
Publicado: (2013)

Anticoagulants/antiplatelets: Bleeding: 14 case reports
Publicado: (2020)

Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review
por: Lau, Kui Kai, et al.
Publicado: (2018)

Risk Factors for Severe Bleeding Complications in Glaucoma Surgery and the Role of Antiplatelet or Anticoagulant Agents
por: Lauermann, Peer, et al.
Publicado: (2022)

P1657: PATTERNS AND PATIENT SPECIFIC FEATURES CHARACTERIZING BLEEDING EVENTS IN PATIENTS ON ANTIPLATELET AND ANTICOAGULANT THERAPY: A TERTIARY CENTER EXPERIENCE
por: Awada, H., et al.
Publicado: (2022)

External Validation of Risk Scores for Major Bleeding in a Population-Based Cohort of Transient Ischemic Attack and Ischemic Stroke Patients
por: Hilkens, Nina A., et al.
Publicado: (2018)

Antiplatelet therapy and the vascular tree
por: Blann, A
Publicado: (2006)

Anticoagulation and antiplatelet therapy in acute coronary syndromes: choosing between the Scylla of bleeding and the Charybdis of ischaemic events
por: de Winter, R. J.
Publicado: (2018)

Post-ERCP Bleeding in the Era of Multiple Antiplatelet Agents
por: Oh, Hyoung-Chul, et al.
Publicado: (2018)

Genetic testing in antiplatelet therapy – not effective for perioperative bleeding
por: Kuliczkowski, Wiktor
Publicado: (2017)

Antiplatelets/enoxaparin-sodium: Major bleeding: case report
Publicado: (2020)

The stent in the high-bleeding risk patient: antiplatelet monotherapy?
por: Capranzano, Piera
Publicado: (2022)

Triple antiplatelet therapy for preventing vascular events: a systematic review and meta-analysis
por: Geeganage, Chamila, et al.
Publicado: (2010)

Delirium risk stratification in consecutive unselected admissions to acute medicine: validation of externally derived risk scores
por: Pendlebury, Sarah T., et al.
Publicado: (2016)

Reversing Bleeding Associated With Antiplatelet Use: The Role of Tranexamic Acid
por: Fischer, Kyle, et al.
Publicado: (2020)

A Novel Coagulation Classification and Postoperative Bleeding in Severe Spontaneous Intracerebral Hemorrhage Patients on Antiplatelet Therapy
por: Liu, Qingyuan, et al.
Publicado: (2022)

Surgeon's guide to anticoagulant and antiplatelet medications part two: antiplatelet agents and perioperative management of long-term anticoagulation
por: Yeung, Louise Y Y, et al.
Publicado: (2016)

Aspirin vs Clopidogrel: Antiplatelet Agent of Choice for Those With Recent Bleeding or at Risk for Gastrointestinal Bleed
por: Gosavi, Siddharth, et al.
Publicado: (2023)

Antiplatelet combinations for prevention of atherothrombotic events
por: Bollati, Mario, et al.
Publicado: (2011)

Gastroscopy-related adverse cardiac events and bleeding complications among patients treated with coronary stents and dual antiplatelet therapy
por: Egholm, Gro, et al.
Publicado: (2016)

Bleeding Risk with Long-Term Low-Dose Aspirin: A Systematic Review of Observational Studies
por: García Rodríguez, Luis A., et al.
Publicado: (2016)

Surgical treatment for antiplatelet intracerebral hemorrhage (SAP-ICH): protocol for a prospective cohort study of emergency surgery for severe spontaneous intracerebral hemorrhage patients on long-term oral antiplatelet treatment
por: Wu, Jun, et al.
Publicado: (2021)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_fssd47a7snn9qgsjj4na03u539